Deng X, He J, Xu J, Wang Y, Yi J, Zhang H
Iran J Basic Med Sci. 2023; 26(5):564-571.
PMID: 37051103
PMC: 10083835.
DOI: 10.22038/IJBMS.2023.67394.14775.
Poetsch A, Marchesini M
Proteomes. 2020; 8(2).
PMID: 32331335
PMC: 7355872.
DOI: 10.3390/proteomes8020008.
Hisham Y, Ashhab Y
J Immunol Res. 2019; 2018:1474517.
PMID: 30622973
PMC: 6304850.
DOI: 10.1155/2018/1474517.
Gheibi A, Khanahmad H, Kashfi K, Sarmadi M, Khorramizadeh M
Heliyon. 2019; 4(12):e01079.
PMID: 30603712
PMC: 6307385.
DOI: 10.1016/j.heliyon.2018.e01079.
Rosenberg R, Fu M, Lambracht-Washington D
J Neuroimmunol. 2018; 322:15-25.
PMID: 29958693
PMC: 6192700.
DOI: 10.1016/j.jneuroim.2018.05.017.
Meta-Analysis and Advancement of Brucellosis Vaccinology.
Carvalho T, Haddad J, Paixao T, Santos R
PLoS One. 2016; 11(11):e0166582.
PMID: 27846274
PMC: 5112997.
DOI: 10.1371/journal.pone.0166582.
Construction of an expression plasmid (vector) encoding Brucella melitensis outer membrane protein, a candidate for DNA vaccine.
Vahedi F, Ghorbani E, Falsafi T
Rep Biochem Mol Biol. 2016; 1(2):82-6.
PMID: 26989713
PMC: 4757060.
A Critical Role of Bacterioferritin in Salmonella pullorum-Induced IFN-β Expression in DF-1 Cells.
Xu Z, Qin Y, Wang Y, Li X, Cao H, Zheng S
Front Microbiol. 2016; 7:20.
PMID: 26870001
PMC: 4737897.
DOI: 10.3389/fmicb.2016.00020.
Recent advances in Brucella abortus vaccines.
Dorneles E, Sriranganathan N, Lage A
Vet Res. 2015; 46:76.
PMID: 26155935
PMC: 4495609.
DOI: 10.1186/s13567-015-0199-7.
Immunization with Brucella VirB proteins reduces organ colonization in mice through a Th1-type immune response and elicits a similar immune response in dogs.
Pollak C, Wanke M, Estein S, Delpino M, Monachesi N, Comercio E
Clin Vaccine Immunol. 2014; 22(3):274-81.
PMID: 25540276
PMC: 4340900.
DOI: 10.1128/CVI.00653-14.
DNA vaccination of bison to brucellar antigens elicits elevated antibody and IFN-γ responses.
Clapp B, Walters N, Thornburg T, Hoyt T, Yang X, Pascual D
J Wildl Dis. 2011; 47(3):501-10.
PMID: 21719815
PMC: 9828159.
DOI: 10.7589/0090-3558-47.3.501.
Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.
Commander N, Brewer J, Wren B, Spencer S, Macmillan A, Stack J
Genet Vaccines Ther. 2010; 8:5.
PMID: 20637091
PMC: 2918601.
DOI: 10.1186/1479-0556-8-5.
Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.
Savitt A, Mena-Taboada P, Monsalve G, Benach J
Clin Vaccine Immunol. 2009; 16(3):414-22.
PMID: 19176692
PMC: 2650858.
DOI: 10.1128/CVI.00362-08.
Enzymatic, immunological and phylogenetic characterization of Brucella suis urease.
Contreras-Rodriguez A, Quiroz-Limon J, Martins A, Peralta H, Avila-Calderon E, Sriranganathan N
BMC Microbiol. 2008; 8:121.
PMID: 18638408
PMC: 2492869.
DOI: 10.1186/1471-2180-8-121.
Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.
Luo D, Ni B, Li P, Shi W, Zhang S, Han Y
Infect Immun. 2006; 74(5):2734-41.
PMID: 16622210
PMC: 1459688.
DOI: 10.1128/IAI.74.5.2734-2741.2006.
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
Yang X, Hudson M, Walters N, Bargatze R, Pascual D
Infect Immun. 2005; 73(11):7297-303.
PMID: 16239526
PMC: 1273852.
DOI: 10.1128/IAI.73.11.7297-7303.2005.
A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response.
Cassataro J, Velikovsky C, de la Barrera S, Estein S, Bruno L, Bowden R
Infect Immun. 2005; 73(10):6537-46.
PMID: 16177328
PMC: 1230944.
DOI: 10.1128/IAI.73.10.6537-6546.2005.
An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
Onate A, Donoso G, Moraga-Cid G, Folch H, Cespedes S, Andrews E
Infect Immun. 2005; 73(6):3294-300.
PMID: 15908354
PMC: 1111843.
DOI: 10.1128/IAI.73.6.3294-3300.2005.
Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells.
Munoz-Montesino C, Andrews E, Rivers R, Gonzalez-Smith A, Moraga-Cid G, Folch H
Infect Immun. 2004; 72(4):2081-7.
PMID: 15039330
PMC: 375181.
DOI: 10.1128/IAI.72.4.2081-2087.2004.
Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.
Velikovsky C, Goldbaum F, Cassataro J, Estein S, Bowden R, Bruno L
Infect Immun. 2003; 71(10):5750-5.
PMID: 14500496
PMC: 201088.
DOI: 10.1128/IAI.71.10.5750-5755.2003.